These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3046349)

  • 21. Comprehensive clinical pharmacy documentation in an out-patient cancer facility.
    Davies NM; Spaven JR; Chambers CR
    Can J Hosp Pharm; 1992 Jun; 45(3):107-11. PubMed ID: 10119690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of pharmacokinetic drug interactions with carbamazepine and phenytoin using stable isotope labeling and simple high-performance liquid chromatography/ultraviolet detection technique.
    Browne TR; Szabo GK; Davoudi H; Josephs EG
    Neurology; 1994 Dec; 44(12):2410-1. PubMed ID: 7991143
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical pharmacokinetics of carbamazepine].
    Kanarkowski R; Rybakowski J
    Psychiatr Pol; 1989; 23(5-6):379-86. PubMed ID: 2485472
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients.
    Haerer AF; Grace JB
    Acta Neurol Scand; 1969; 45(1):18-31. PubMed ID: 4979531
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient care contributions of clinical pharmacists in four ambulatory care clinics.
    Hatoum HT; Witte KW; Hutchinson RA
    Hosp Pharm; 1992 Mar; 27(3):203-6, 208-9. PubMed ID: 10116720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Rackley RJ
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118860
    [No Abstract]   [Full Text] [Related]  

  • 29. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Stetz SA
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118861
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Population pharmacokinetics of carbamazepine in adults with epilepsy].
    Romano-Moreno S; Medina-Rojas EL; Salas-Ortiz AL; Vargas-Morales JM; Pérez-Urizar JT; Rodríguez-Leyva I
    Rev Invest Clin; 2005; 57(1):38-48. PubMed ID: 15981957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a clinical psychopharmacy consultation service on patient outcomes.
    Stanislav SW; Barker K; Crismon ML; Childs A
    Am J Hosp Pharm; 1994 Mar; 51(6):778-81. PubMed ID: 8010316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Jefferys RJ
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16116145
    [No Abstract]   [Full Text] [Related]  

  • 34. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Referral approach for patient education in an ambulatory-care pharmacy.
    Munroe WP; Groh MJ
    Am J Hosp Pharm; 1985 Mar; 42(3):624-5. PubMed ID: 3985028
    [No Abstract]   [Full Text] [Related]  

  • 36. The provision of pharmaceutical care in a Veterans' Affairs Medical Center outpatient HIV clinic.
    Warnock AC; Rimland D
    Hosp Pharm; 1994 Feb; 29(2):114-6, 119-20. PubMed ID: 10132150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collaborative clinical pharmacokinetics service in a community hospital.
    Rietscha WJ; Heissler JF; Paulson MF; Stockmar RA; Bessert JA; Melby MJ
    Am J Hosp Pharm; 1984 Mar; 41(3):473-7. PubMed ID: 6702850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
    Brostoff JM; Birns J; McCrea D
    J Clin Pharm Ther; 2008 Apr; 33(2):211-4. PubMed ID: 18315788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computerized pharmacokinetics on an institutional clinical information system.
    Chrymko MM; Scherpbier HJ
    Pharm Pract Manag Q; 1995 Oct; 15(3):36-43. PubMed ID: 10151711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seven years of experience with a pharmacokinetic service.
    Job ML; Ward ES; Murphy JE
    Hosp Pharm; 1989 Jul; 24(7):512-9, 526. PubMed ID: 10318293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.